855 Participants Needed

Swallowing Assessment Protocols for Aspiration in Respiratory Failure Survivors

Recruiting at 4 trial locations
JM
EJ
JM
Overseen ByJeff McKeehan, RN,MSN
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: University of Colorado, Denver
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

Trial Summary

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.

What data supports the effectiveness of the treatment 3-Screenings Protocol, FEES, Tracheal Ultrasound for aspiration in respiratory failure survivors?

Research shows that using ultrasound to observe swallowing can help improve safe eating and drinking in people with swallowing problems, reducing the risk of choking and pneumonia. This suggests that tracheal ultrasound, as part of the treatment, may be effective in assessing and managing swallowing issues in respiratory failure survivors.12345

Is the Swallowing Assessment Protocol safe for humans?

Research shows that using ultrasound for swallowing assessments is generally safe, as no cases of pneumonia or suffocation were reported during studies. This suggests that the protocol is safe for humans.12456

How does the swallowing assessment protocol treatment differ from other treatments for aspiration in respiratory failure survivors?

The swallowing assessment protocol is unique because it focuses on bedside evaluations to detect aspiration risk in respiratory failure survivors, aiming to reduce complications and allow for timely oral nutrition. This approach is less invasive compared to other methods like fiberoptic endoscopic evaluation of swallowing (FEES), which requires specialized equipment and expertise.24789

What is the purpose of this trial?

The purpose of this study is to learn more about problems with swallowing that could develop in patients who are very sick and need a machine to help them breathe.

Research Team

Our current team

Marc Moss, MD

Principal Investigator

University of Colorado, Denver

Eligibility Criteria

This trial is for adults who've been in the ICU and on a ventilator for over 48 hours. It's not suitable for those with uncontrolled bleeding, persistent delirium after extubation, neuromuscular disorders, chronic tracheostomy before ICU admission, head and neck cancer or surgery history, under 18s, prior swallowing issues or aspiration history.

Inclusion Criteria

I have been on a breathing machine with a tube for more than 2 days.
I have been admitted to an intensive care unit.

Exclusion Criteria

I have a muscle or nerve disorder affecting my brain, spinal cord, or nerves.
Inability to obtain informed consent from patient or an appropriate surrogate
You have been breathing without a tube for more than 72 hours.
See 7 more

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Pre-Extubation Assessment

Participants receive a tracheal ultrasound within 72 hours prior to extubation and collection of demographic and hospital clinical information

Up to 3 days

Post-Extubation Assessment

Administration of 3 screening tests addressing swallowing function within 24 hours post-extubation and a fiberoptic endoscopic examination of swallowing (FEES) exam

1 day

Follow-up

Participants are monitored for post-extubation dysphagia and aspiration from extubation day 1 through hospital discharge

Up to 28 days

Treatment Details

Interventions

  • 3-Screenings Protocol
  • FEES
  • Tracheal Ultrasound
Trial Overview The study tests three methods to understand swallowing problems post-acute respiratory failure: FEES (a type of swallow test), a protocol involving three screenings for swallowing safety, and tracheal ultrasound to assess airway management.
Participant Groups
1Treatment groups
Experimental Treatment
Group I: Aspiration in Acute Respiratory Failure SurvivorsExperimental Treatment3 Interventions
All participants will receive a tracheal ultrasound within 72 hours prior to extubation, collection of demographic and hospital clinical information, administration of 3 screening tests (study defined algorithm test, 3-ounce water swallow test, TOR-BSST) addressing swallowing function within 24 hours post-extubation, and a fiberoptic endoscopic examination of swallowing (FEES) exam.

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of Colorado, Denver

Lead Sponsor

Trials
1,842
Recruited
3,028,000+

National Institute of Nursing Research (NINR)

Collaborator

Trials
623
Recruited
10,400,000+

Findings from Research

Ultrasonography has good diagnostic accuracy for detecting aspiration in patients with dysphagia, with a pooled sensitivity of 82% and specificity of 87% based on five studies.
While ultrasound is a promising non-invasive screening tool for aspiration, its effectiveness in detecting pharyngeal residue is lower, with sensitivity at 62% and specificity at 67%, and the overall certainty of evidence is low.
Diagnostic accuracy of ultrasound examination in detecting aspiration and pharyngeal residue in patients with dysphagia: A systematic review and meta-analysis.Miura, Y., Tamai, N., Kitamura, A., et al.[2021]
A bedside swallowing assessment conducted on 94 stroke patients showed low sensitivity (47%) for detecting aspiration, meaning it often missed cases where patients were aspirating, despite having a higher specificity (86%).
The study suggests that while bedside assessments are not reliable for screening aspiration in acute stroke patients, certain indicators like a weak voluntary cough and altered consciousness could improve prediction accuracy, achieving a sensitivity of 75% and a negative predictive value of 91%.
Can bedside assessment reliably exclude aspiration following acute stroke?Smithard, DG., O'Neill, PA., Park, C., et al.[2019]
Ultrasonic measurements of swallowing movement parameters can effectively identify and assess the severity of swallowing dysfunction in patients with chronic obstructive pulmonary disease (COPD), based on a study of 220 patients (120 with dysfunction and 100 without).
Key parameters such as hyoid muscle thickness and geniohyoid muscle movement distance were found to be lower in COPD patients with swallowing issues, indicating a strong correlation between these measurements and the severity of swallowing dysfunction.
Assessing Swallowing Dysfunction Aggravation in Chronic Obstructive Pulmonary Disease Patients Using Ultrasonic Measurements With Swallowing Movement Parameters.Huang, Y., Zhong, H., Xu, Z., et al.[2023]

References

Diagnostic accuracy of ultrasound examination in detecting aspiration and pharyngeal residue in patients with dysphagia: A systematic review and meta-analysis. [2021]
Can bedside assessment reliably exclude aspiration following acute stroke? [2019]
Assessing Swallowing Dysfunction Aggravation in Chronic Obstructive Pulmonary Disease Patients Using Ultrasonic Measurements With Swallowing Movement Parameters. [2023]
Swallowing and Aspiration Risk: A Critical Review of Non Instrumental Bedside Screening Tests. [2023]
Effectiveness of Swallowing Care on Safe Oral Intake Using Ultrasound-Based Observation of Residues in the Epiglottis Valley: A Pragmatic, Quasi-Experimental Study. [2020]
A Randomized Controlled Trial to Investigate the Effectiveness of the Prevention of Aspiration Pneumonia Using Recommendations for Swallowing Care Guided by Ultrasound Examination. [2020]
Early assessment of aspiration risk in acute stroke by fiberoptic endoscopy in critically ill patients. [2022]
The accuracy of the bedside swallowing evaluation for detecting aspiration in survivors of acute respiratory failure. [2018]
FEES protocol derived estimates of sensitivity: aspiration in dysphagic patients. [2021]
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security